0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CircRNA Synthesis Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-3C17633
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global CircRNA Synthesis Service Market Research Report 2024
BUY CHAPTERS

Global CircRNA Synthesis Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-3C17633
Report
October 2025
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

CircRNA Synthesis Service Market

The global CircRNA Synthesis Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
CircRNA is a type of RNA molecule with a circular structure. From initially thinking it was useless to now discovering that it has important and complex functions, the importance of circRNA is increasingly being recognized. circRNA was first discovered as an ncRNA with a molecular sponge function. Clinically, due to its special molecular structure, researchers are generally interested in its potential as a biomarker. Recently, circRNA has been proven to have many functions other than encoding proteins. In the clinical setting, circRNA also has strong potential for application in vaccine preparation and targeted therapy.
From a downstream perspective, Drug Discovery accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
CircRNA Synthesis Service leading manufacturers including GenScript, Guangzhou IGE Biotechnology, Geneseed, Azenta Life Sciences, Beyotime, Packgene Biotech, Yaohai Biological, Creative Biogene, LGC Biosearch Technologies, CircNova, etc., dominate supply; the top five capture approximately % of global revenue, with GenScript leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global CircRNA Synthesis Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of CircRNA Synthesis Service Market Report

Report Metric Details
Report Name CircRNA Synthesis Service Market
Segment by Type
  • Chemical Synthesis Method
  • Ligase Method
  • Ribozyme Method
Segment by Application
  • Drug Discovery
  • Cell Therapy
  • Vaccine R&D
  • Disease Mechanism
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GenScript, Guangzhou IGE Biotechnology, Geneseed, Azenta Life Sciences, Beyotime, Packgene Biotech, Yaohai Biological, Creative Biogene, LGC Biosearch Technologies, CircNova, BOC Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the CircRNA Synthesis Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the CircRNA Synthesis Service Market report?

Ans: The main players in the CircRNA Synthesis Service Market are GenScript, Guangzhou IGE Biotechnology, Geneseed, Azenta Life Sciences, Beyotime, Packgene Biotech, Yaohai Biological, Creative Biogene, LGC Biosearch Technologies, CircNova, BOC Sciences

What are the Application segmentation covered in the CircRNA Synthesis Service Market report?

Ans: The Applications covered in the CircRNA Synthesis Service Market report are Drug Discovery, Cell Therapy, Vaccine R&D, Disease Mechanism

What are the Type segmentation covered in the CircRNA Synthesis Service Market report?

Ans: The Types covered in the CircRNA Synthesis Service Market report are Chemical Synthesis Method, Ligase Method, Ribozyme Method

1 Study Coverage
1.1 Introduction to CircRNA Synthesis Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global CircRNA Synthesis Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Chemical Synthesis Method
1.2.3 Ligase Method
1.2.4 Ribozyme Method
1.3 Market Segmentation by Application
1.3.1 Global CircRNA Synthesis Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Drug Discovery
1.3.3 Cell Therapy
1.3.4 Vaccine R&D
1.3.5 Disease Mechanism
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global CircRNA Synthesis Service Revenue Estimates and Forecasts 2020-2031
2.2 Global CircRNA Synthesis Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global CircRNA Synthesis Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global CircRNA Synthesis Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Chemical Synthesis Method Market Size by Players
3.3.2 Ligase Method Market Size by Players
3.3.3 Ribozyme Method Market Size by Players
3.4 Global CircRNA Synthesis Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global CircRNA Synthesis Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global CircRNA Synthesis Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America CircRNA Synthesis Service Market Size by Type (2020-2031)
6.4 North America CircRNA Synthesis Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America CircRNA Synthesis Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe CircRNA Synthesis Service Market Size by Type (2020-2031)
7.4 Europe CircRNA Synthesis Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe CircRNA Synthesis Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific CircRNA Synthesis Service Market Size by Type (2020-2031)
8.4 Asia-Pacific CircRNA Synthesis Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific CircRNA Synthesis Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America CircRNA Synthesis Service Market Size by Type (2020-2031)
9.4 Central and South America CircRNA Synthesis Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America CircRNA Synthesis Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa CircRNA Synthesis Service Market Size by Type (2020-2031)
10.4 Middle East and Africa CircRNA Synthesis Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa CircRNA Synthesis Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 GenScript
11.1.1 GenScript Corporation Information
11.1.2 GenScript Business Overview
11.1.3 GenScript CircRNA Synthesis Service Product Features and Attributes
11.1.4 GenScript CircRNA Synthesis Service Revenue and Gross Margin (2020-2025)
11.1.5 GenScript CircRNA Synthesis Service Revenue by Product in 2024
11.1.6 GenScript CircRNA Synthesis Service Revenue by Application in 2024
11.1.7 GenScript CircRNA Synthesis Service Revenue by Geographic Area in 2024
11.1.8 GenScript CircRNA Synthesis Service SWOT Analysis
11.1.9 GenScript Recent Developments
11.2 Guangzhou IGE Biotechnology
11.2.1 Guangzhou IGE Biotechnology Corporation Information
11.2.2 Guangzhou IGE Biotechnology Business Overview
11.2.3 Guangzhou IGE Biotechnology CircRNA Synthesis Service Product Features and Attributes
11.2.4 Guangzhou IGE Biotechnology CircRNA Synthesis Service Revenue and Gross Margin (2020-2025)
11.2.5 Guangzhou IGE Biotechnology CircRNA Synthesis Service Revenue by Product in 2024
11.2.6 Guangzhou IGE Biotechnology CircRNA Synthesis Service Revenue by Application in 2024
11.2.7 Guangzhou IGE Biotechnology CircRNA Synthesis Service Revenue by Geographic Area in 2024
11.2.8 Guangzhou IGE Biotechnology CircRNA Synthesis Service SWOT Analysis
11.2.9 Guangzhou IGE Biotechnology Recent Developments
11.3 Geneseed
11.3.1 Geneseed Corporation Information
11.3.2 Geneseed Business Overview
11.3.3 Geneseed CircRNA Synthesis Service Product Features and Attributes
11.3.4 Geneseed CircRNA Synthesis Service Revenue and Gross Margin (2020-2025)
11.3.5 Geneseed CircRNA Synthesis Service Revenue by Product in 2024
11.3.6 Geneseed CircRNA Synthesis Service Revenue by Application in 2024
11.3.7 Geneseed CircRNA Synthesis Service Revenue by Geographic Area in 2024
11.3.8 Geneseed CircRNA Synthesis Service SWOT Analysis
11.3.9 Geneseed Recent Developments
11.4 Azenta Life Sciences
11.4.1 Azenta Life Sciences Corporation Information
11.4.2 Azenta Life Sciences Business Overview
11.4.3 Azenta Life Sciences CircRNA Synthesis Service Product Features and Attributes
11.4.4 Azenta Life Sciences CircRNA Synthesis Service Revenue and Gross Margin (2020-2025)
11.4.5 Azenta Life Sciences CircRNA Synthesis Service Revenue by Product in 2024
11.4.6 Azenta Life Sciences CircRNA Synthesis Service Revenue by Application in 2024
11.4.7 Azenta Life Sciences CircRNA Synthesis Service Revenue by Geographic Area in 2024
11.4.8 Azenta Life Sciences CircRNA Synthesis Service SWOT Analysis
11.4.9 Azenta Life Sciences Recent Developments
11.5 Beyotime
11.5.1 Beyotime Corporation Information
11.5.2 Beyotime Business Overview
11.5.3 Beyotime CircRNA Synthesis Service Product Features and Attributes
11.5.4 Beyotime CircRNA Synthesis Service Revenue and Gross Margin (2020-2025)
11.5.5 Beyotime CircRNA Synthesis Service Revenue by Product in 2024
11.5.6 Beyotime CircRNA Synthesis Service Revenue by Application in 2024
11.5.7 Beyotime CircRNA Synthesis Service Revenue by Geographic Area in 2024
11.5.8 Beyotime CircRNA Synthesis Service SWOT Analysis
11.5.9 Beyotime Recent Developments
11.6 Packgene Biotech
11.6.1 Packgene Biotech Corporation Information
11.6.2 Packgene Biotech Business Overview
11.6.3 Packgene Biotech CircRNA Synthesis Service Product Features and Attributes
11.6.4 Packgene Biotech CircRNA Synthesis Service Revenue and Gross Margin (2020-2025)
11.6.5 Packgene Biotech Recent Developments
11.7 Yaohai Biological
11.7.1 Yaohai Biological Corporation Information
11.7.2 Yaohai Biological Business Overview
11.7.3 Yaohai Biological CircRNA Synthesis Service Product Features and Attributes
11.7.4 Yaohai Biological CircRNA Synthesis Service Revenue and Gross Margin (2020-2025)
11.7.5 Yaohai Biological Recent Developments
11.8 Creative Biogene
11.8.1 Creative Biogene Corporation Information
11.8.2 Creative Biogene Business Overview
11.8.3 Creative Biogene CircRNA Synthesis Service Product Features and Attributes
11.8.4 Creative Biogene CircRNA Synthesis Service Revenue and Gross Margin (2020-2025)
11.8.5 Creative Biogene Recent Developments
11.9 LGC Biosearch Technologies
11.9.1 LGC Biosearch Technologies Corporation Information
11.9.2 LGC Biosearch Technologies Business Overview
11.9.3 LGC Biosearch Technologies CircRNA Synthesis Service Product Features and Attributes
11.9.4 LGC Biosearch Technologies CircRNA Synthesis Service Revenue and Gross Margin (2020-2025)
11.9.5 LGC Biosearch Technologies Recent Developments
11.10 CircNova
11.10.1 CircNova Corporation Information
11.10.2 CircNova Business Overview
11.10.3 CircNova CircRNA Synthesis Service Product Features and Attributes
11.10.4 CircNova CircRNA Synthesis Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 BOC Sciences
11.11.1 BOC Sciences Corporation Information
11.11.2 BOC Sciences Business Overview
11.11.3 BOC Sciences CircRNA Synthesis Service Product Features and Attributes
11.11.4 BOC Sciences CircRNA Synthesis Service Revenue and Gross Margin (2020-2025)
11.11.5 BOC Sciences Recent Developments
12 CircRNA Synthesis ServiceIndustry Chain Analysis
12.1 CircRNA Synthesis Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 CircRNA Synthesis Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global CircRNA Synthesis Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global CircRNA Synthesis Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global CircRNA Synthesis Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global CircRNA Synthesis Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global CircRNA Synthesis Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global CircRNA Synthesis Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global CircRNA Synthesis Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global CircRNA Synthesis Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CircRNA Synthesis Service as of 2024)
 Table 11. Global CircRNA Synthesis Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global CircRNA Synthesis Service Companies Headquarters
 Table 13. Global CircRNA Synthesis Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global CircRNA Synthesis Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global CircRNA Synthesis Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global CircRNA Synthesis Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global CircRNA Synthesis Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. CircRNA Synthesis Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America CircRNA Synthesis Service Growth Accelerators and Market Barriers
 Table 25. North America CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe CircRNA Synthesis Service Growth Accelerators and Market Barriers
 Table 27. Europe CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific CircRNA Synthesis Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America CircRNA Synthesis Service Investment Opportunities and Key Challenges
 Table 31. Central and South America CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa CircRNA Synthesis Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. GenScript Corporation Information
 Table 35. GenScript Description and Major Businesses
 Table 36. GenScript Product Features and Attributes
 Table 37. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. GenScript Revenue Proportion by Product in 2024
 Table 39. GenScript Revenue Proportion by Application in 2024
 Table 40. GenScript Revenue Proportion by Geographic Area in 2024
 Table 41. GenScript CircRNA Synthesis Service SWOT Analysis
 Table 42. GenScript Recent Developments
 Table 43. Guangzhou IGE Biotechnology Corporation Information
 Table 44. Guangzhou IGE Biotechnology Description and Major Businesses
 Table 45. Guangzhou IGE Biotechnology Product Features and Attributes
 Table 46. Guangzhou IGE Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Guangzhou IGE Biotechnology Revenue Proportion by Product in 2024
 Table 48. Guangzhou IGE Biotechnology Revenue Proportion by Application in 2024
 Table 49. Guangzhou IGE Biotechnology Revenue Proportion by Geographic Area in 2024
 Table 50. Guangzhou IGE Biotechnology CircRNA Synthesis Service SWOT Analysis
 Table 51. Guangzhou IGE Biotechnology Recent Developments
 Table 52. Geneseed Corporation Information
 Table 53. Geneseed Description and Major Businesses
 Table 54. Geneseed Product Features and Attributes
 Table 55. Geneseed Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Geneseed Revenue Proportion by Product in 2024
 Table 57. Geneseed Revenue Proportion by Application in 2024
 Table 58. Geneseed Revenue Proportion by Geographic Area in 2024
 Table 59. Geneseed CircRNA Synthesis Service SWOT Analysis
 Table 60. Geneseed Recent Developments
 Table 61. Azenta Life Sciences Corporation Information
 Table 62. Azenta Life Sciences Description and Major Businesses
 Table 63. Azenta Life Sciences Product Features and Attributes
 Table 64. Azenta Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Azenta Life Sciences Revenue Proportion by Product in 2024
 Table 66. Azenta Life Sciences Revenue Proportion by Application in 2024
 Table 67. Azenta Life Sciences Revenue Proportion by Geographic Area in 2024
 Table 68. Azenta Life Sciences CircRNA Synthesis Service SWOT Analysis
 Table 69. Azenta Life Sciences Recent Developments
 Table 70. Beyotime Corporation Information
 Table 71. Beyotime Description and Major Businesses
 Table 72. Beyotime Product Features and Attributes
 Table 73. Beyotime Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Beyotime Revenue Proportion by Product in 2024
 Table 75. Beyotime Revenue Proportion by Application in 2024
 Table 76. Beyotime Revenue Proportion by Geographic Area in 2024
 Table 77. Beyotime CircRNA Synthesis Service SWOT Analysis
 Table 78. Beyotime Recent Developments
 Table 79. Packgene Biotech Corporation Information
 Table 80. Packgene Biotech Description and Major Businesses
 Table 81. Packgene Biotech Product Features and Attributes
 Table 82. Packgene Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Packgene Biotech Recent Developments
 Table 84. Yaohai Biological Corporation Information
 Table 85. Yaohai Biological Description and Major Businesses
 Table 86. Yaohai Biological Product Features and Attributes
 Table 87. Yaohai Biological Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Yaohai Biological Recent Developments
 Table 89. Creative Biogene Corporation Information
 Table 90. Creative Biogene Description and Major Businesses
 Table 91. Creative Biogene Product Features and Attributes
 Table 92. Creative Biogene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Creative Biogene Recent Developments
 Table 94. LGC Biosearch Technologies Corporation Information
 Table 95. LGC Biosearch Technologies Description and Major Businesses
 Table 96. LGC Biosearch Technologies Product Features and Attributes
 Table 97. LGC Biosearch Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. LGC Biosearch Technologies Recent Developments
 Table 99. CircNova Corporation Information
 Table 100. CircNova Description and Major Businesses
 Table 101. CircNova Product Features and Attributes
 Table 102. CircNova Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. CircNova Recent Developments
 Table 104. BOC Sciences Corporation Information
 Table 105. BOC Sciences Description and Major Businesses
 Table 106. BOC Sciences Product Features and Attributes
 Table 107. BOC Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. BOC Sciences Recent Developments
 Table 109. Raw Materials Key Suppliers
 Table 110. Distributors List
 Table 111. Market Trends and Market Evolution
 Table 112. Market Drivers and Opportunities
 Table 113. Market Challenges, Risks, and Restraints
 Table 114. Research Programs/Design for This Report
 Table 115. Key Data Information from Secondary Sources
 Table 116. Key Data Information from Primary Sources


List of Figures
 Figure 1. CircRNA Synthesis Service Product Picture
 Figure 2. Global CircRNA Synthesis Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Chemical Synthesis Method Product Picture
 Figure 4. Ligase Method Product Picture
 Figure 5. Ribozyme Method Product Picture
 Figure 6. Global CircRNA Synthesis Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Drug Discovery
 Figure 8. Cell Therapy
 Figure 9. Vaccine R&D
 Figure 10. Disease Mechanism
 Figure 11. CircRNA Synthesis Service Report Years Considered
 Figure 12. Global CircRNA Synthesis Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 14. Global CircRNA Synthesis Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global CircRNA Synthesis Service Revenue Market Share by Region (2020-2031)
 Figure 16. Global CircRNA Synthesis Service Revenue Market Share Ranking (2024)
 Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 18. Chemical Synthesis Method Revenue Market Share by Player in 2024
 Figure 19. Ligase Method Revenue Market Share by Player in 2024
 Figure 20. Ribozyme Method Revenue Market Share by Player in 2024
 Figure 21. Global CircRNA Synthesis Service Revenue Market Share by Type (2020-2031)
 Figure 22. Global CircRNA Synthesis Service Revenue Market Share by Application (2020-2031)
 Figure 23. North America CircRNA Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 24. North America Top 5 Players CircRNA Synthesis Service Revenue (US$ Million) in 2024
 Figure 25. North America CircRNA Synthesis Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 26. North America CircRNA Synthesis Service Revenue (US$ Million) by Application (2020-2031)
 Figure 27. US CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 28. Canada CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 29. Mexico CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 30. Europe CircRNA Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. Europe Top 5 Players CircRNA Synthesis Service Revenue (US$ Million) in 2024
 Figure 32. Europe CircRNA Synthesis Service Revenue (US$ Million) by Type (2020-2031)
 Figure 33. Europe CircRNA Synthesis Service Revenue (US$ Million) by Application (2020-2031)
 Figure 34. Germany CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 35. France CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 36. U.K. CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 37. Italy CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 38. Russia CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific CircRNA Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Top 8 Players CircRNA Synthesis Service Revenue (US$ Million) in 2024
 Figure 41. Asia-Pacific CircRNA Synthesis Service Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Asia-Pacific CircRNA Synthesis Service Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Indonesia CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 44. Japan CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 45. South Korea CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 46. Australia CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 47. India CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 48. Indonesia CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Vietnam CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Malaysia CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Philippines CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 52. Singapore CircRNA Synthesis Service Revenue (2020-2031) & (US$ Million)
 Figure 53. Central and South America CircRNA Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Central and South America Top 5 Players CircRNA Synthesis Service Revenue (US$ Million) in 2024
 Figure 55. Central and South America CircRNA Synthesis Service Revenue (US$ Million) by Type (2020-2031)
 Figure 56. Central and South America CircRNA Synthesis Service Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Brazil CircRNA Synthesis Service Revenue (2020-2025) & (US$ Million)
 Figure 58. Argentina CircRNA Synthesis Service Revenue (2020-2025) & (US$ Million)
 Figure 59. Middle East and Africa CircRNA Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Middle East and Africa Top 5 Players CircRNA Synthesis Service Revenue (US$ Million) in 2024
 Figure 61. South America CircRNA Synthesis Service Revenue (US$ Million) by Type (2020-2031)
 Figure 62. Middle East and Africa CircRNA Synthesis Service Revenue (US$ Million) by Application (2020-2031)
 Figure 63. GCC Countries CircRNA Synthesis Service Revenue (2020-2025) & (US$ Million)
 Figure 64. Israel CircRNA Synthesis Service Revenue (2020-2025) & (US$ Million)
 Figure 65. Egypt CircRNA Synthesis Service Revenue (2020-2025) & (US$ Million)
 Figure 66. South Africa CircRNA Synthesis Service Revenue (2020-2025) & (US$ Million)
 Figure 67. CircRNA Synthesis Service Industry Chain Mapping
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc